Prostate cancer (PCa) is the most common cancer and the third leading cause of cancer-related death among men in France. Active surveillance is one of the management options for low-risk prostate cancer. Its aim is to delay or avoid radical treatment, such as surgery or radiotherapy, which can cause side effects including urinary incontinence, erectile dysfunction, or radiation-induced cystitis. Active surveillance involves regular monitoring of potential tumor progression through serum PSA testing, MRI scans, and prostate biopsies. Few studies have investigated the psychological adjustment of patients undergoing active surveillance for prostate cancer, and even fewer have explored the relationship between the patients' anxiety symptoms and those of their partners. To our knowledge, no study has yet quantitatively or qualitatively assessed the anxiety of both patients and their partners. It appears essential to better characterize the anxiety symptoms in these individuals in order to offer them appropriate psychological support.
Study Type
OBSERVATIONAL
Enrollment
432
* First, a quantitative cross-sectional study of patients on active surveillance at Lille University Hospital, which will aim to determine the prevalence of anxiety disorders in patients and, if possible, in their partners. * Then, a qualitative study to explore the potential causes of this anxiety.
CHU de Lille
Lille, France
RECRUITINGPrevalence of anxiety symptoms in patients under active surveillance for prostate cancer.
Total score of the 'Memorial Anxiety Scale for Prostate Cancer' questionnaire, whose French translation has been validated (Touzani et al., 2019). Patients scoring \>27/54 are classified as anxious.
Time frame: 12 months
Prevalence of anxiety symptoms in the partners of patients under active surveillance for prostate cancer
Questionnaire assessing anxiety (STAI-Y questionnaire).
Time frame: 12 months
To determine the clinical predictive factors of anxiety in patients on active surveillance.
Use of questionnaires assessing general anxiety (STAI-Y questionnaire) in patients and their partners.
Time frame: 12 months
To determine the predictive factors of anxiety in terms of personal and dyadic coping strategies.
Assessment of intra- and interpersonal emotional skills.
Time frame: 12 months
To identify the potential causes of anxiety.
Participants scoring between 115 and 145 on the DCI are considered within the normal range. A score below 115 indicates that participants use dyadic coping strategies less frequently than average. A score above 145 indicates that participants use dyadic coping strategies more frequently than average.
Time frame: 12 months
Determine the predictive factors of anxiety in terms of interpersonal skills in patients and their partners.
Assessment of intra- and interpersonal emotional skills.
Time frame: 12 months
Prevalence of anxiety symptoms in the partners of patients under active surveillance for prostate
Questionnaire assessing the management of emotions (S-PEC questionnaire).
Time frame: 12 months
Prevalence of anxiety symptoms in the partners of patients under active surveillance for prostate
Questionnaire assessing the stress (Dyadic coping inventory questionnaire).
Time frame: 12 months
To determine the clinical predictive factors of anxiety in patients on active surveillance.
Use of questionnaires assessing the stress (Dyadic coping inventory questionnaire) in patients and their partners.
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.